Glaucoma, the second leading cause of blindness globally, affects millions and is projected to reach 111.8 million cases by ...

The rates at which ganglion cell-inner plexiform layer (GCIPL) and retinal nerve fiber layer (RNFL) thin in the eyes was ...

Artificial intelligence-enabled discovery of a RIPK3 inhibitor with neuroprotective effects in an acute glaucoma mouse model ...

Glaucoma is a progressive eye disorder characterized by fluid buildup inside the eye, causing ocular hypertension. By 2040, ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Sigma-2 receptor modulation using exogenous ligands reduces cellular damage associated with central nervous system degeneration in age-related pathologies such as Alzheimer’s disease, Parkinson’s ...

GlobalData predicts that six late-stage pipeline products are set to enter the glaucoma market during the forecast period.

From redness to gradual loss of vision to constant irritation, here are the early warning signs of eye diseases that should ...

Glaucoma patients show slower visual response times, indicating impaired visual signal processing rather than motor or ...

Diabetes affects millions worldwide, and while most know about its impact on blood sugar and organ health, vision loss ...